CRT-70 The Resolute Zotarolimus-eluting Stent Is Equally Safe And Effective In Women And Men With Coronary Artery Disease: Two-year Outcomes From The Pooled Resolute Clinical Program

Historically, women with cardiovascular (CV) disease have more comorbidities and a higher risk for major CV events and death than men. Outcomes following percutaneous coronary intervention with new generation drug-eluting stents suggest this disparity between sexes is decreasing. Nevertheless, there